Skip to content

Clinical trials

Atherosclerosis trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Belgium Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20074
20082
20092
20119
20124
20132
20141
20151
20163
20171
20182
20201
20212
20223
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting4
Recruiting4
Not yet recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation7
Abbott Medical Devices4
Amgen3
Biotronik AG3
Eli Lilly and Company3
GlaxoSmithKline3
CSL Behring2
Novartis Pharmaceuticals2
Universitaire Ziekenhuizen KU Leuven2
University Hospital, Antwerp2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis47
Coronary Artery Disease12
Peripheral Arterial Disease10
Cardiovascular Diseases6
Arteriosclerosis4
Heart Diseases4
Vascular Diseases4
Acute Coronary Syndrome3
Arterial Occlusive Diseases3
Coronary Disease3

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.